High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma
Titel:
High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma
Auteur:
Arang, Nadia Lubrano, Simone Ceribelli, Michele Rigiracciolo, Damiano C. Saddawi-Konefka, Robert Faraji, Farhoud Ramirez, Sydney I. Kim, Daehwan Tosto, Frances A. Stevenson, Erica Zhou, Yuan Wang, Zhiyong Bogomolovas, Julius Molinolo, Alfredo A. Swaney, Danielle L. Krogan, Nevan J. Yang, Jing Coma, Silvia Pachter, Jonathan A. Aplin, Andrew E. Alessi, Dario R. Thomas, Craig J. Gutkind, J. Silvio